NACo Blog: Opioid legislation stalls in Senate following House approval of bills in June
As the November midterm elections draw closer, the U.S. Senate is increasingly expected to delay consideration of legislation focused on addressing the opioid crisis until after the elections. This impasse follows significant movement in both chambers and the passage of comprehensive opioid legislation in the U.S. House of Representatives in June. The Senate’s delay comes after members…
Details